Being told that you have a “fatty liver” can sound oddly casual, like your liver simply enjoyed one too many cheeseburgers. In reality, fatty liver disease is a medical condition with several possible causes, different levels of severity, and a surprisingly large cast of healthcare professionals who may become involved in your care.
Your primary care doctor may discover the problem during routine bloodwork. A gastroenterologist may investigate abnormal liver enzymes. A hepatologist may assess liver scarring. An endocrinologist may help control diabetes, while a registered dietitian works on an eating plan that does not require surviving on celery and regret.
Understanding which fatty liver disease specialist to see can help you obtain the right tests, avoid unnecessary procedures, and focus on the health risks that matter most. Here is what to know about specialists, referrals, diagnostic testing, treatment, and the experience of navigating fatty liver care.
Understanding the New Fatty Liver Disease Terminology
Medical terminology for fatty liver disease has changed. What was widely called nonalcoholic fatty liver disease, or NAFLD, is now usually called metabolic dysfunction-associated steatotic liver disease, or MASLD.
MASLD refers to excess liver fat occurring alongside at least one cardiometabolic risk factor, such as obesity, Type 2 diabetes, high blood pressure, abnormal cholesterol levels, or insulin resistance.
The more aggressive form, previously called nonalcoholic steatohepatitis or NASH, is now called metabolic dysfunction-associated steatohepatitis, or MASH. In MASH, liver fat is accompanied by inflammation and liver cell injury. Some people develop fibrosis, meaning scar tissue gradually replaces healthy liver tissue.
MASLD does not automatically mean MASH, and MASH does not automatically mean cirrhosis. The specialist’s most important job is often determining where a person falls along that spectrum.
Alcohol can also contribute to steatotic liver disease. Some people have both metabolic risk factors and clinically significant alcohol intake, so a doctor should ask about alcohol use without making assumptions or turning the appointment into a courtroom drama.
Research basis: NIDDK, AASLD, Mayo Clinic and Cleveland Clinic.
What Kind of Doctor Treats Fatty Liver Disease?
Primary care physicians
A primary care physician is often the first professional to identify possible fatty liver disease. The clue may be elevated ALT or AST levels, an ultrasound performed for another reason, or metabolic conditions that increase liver risk.
Primary care doctors can review medications, order initial blood tests, calculate a fibrosis risk score, discuss weight management, and treat related problems such as high cholesterol or hypertension. Many people with low-risk MASLD can continue receiving most of their care in a primary care setting with periodic monitoring.
Gastroenterologists
A gastroenterologist treats diseases involving the digestive system, including the liver, gallbladder, pancreas, stomach, and intestines. Many gastroenterologists diagnose and manage fatty liver disease, particularly when liver enzymes remain abnormal or additional testing is required.
A gastroenterologist may also be helpful when symptoms or test results suggest another digestive or liver condition. Fat in the liver is not always caused by metabolic disease, so doctors may need to consider viral hepatitis, autoimmune liver disease, medication-related injury, iron overload, or other conditions.
Hepatologists
A hepatologist is a physician who specializes more specifically in liver disease. Hepatologists usually complete training in gastroenterology followed by additional expertise in liver disorders.
A hepatology referral becomes particularly valuable when there is concern about MASH, significant fibrosis, cirrhosis, unexplained liver abnormalities, or eligibility for liver-directed medication. A hepatologist may interpret elastography, decide whether a biopsy is appropriate, manage cirrhosis complications, and coordinate liver cancer surveillance when needed.
Transplant hepatologists and surgeons
Most people with fatty liver disease will never require a liver transplant. However, advanced MASH can lead to decompensated cirrhosis, liver failure, or liver cancer. In those circumstances, a transplant hepatologist evaluates liver function, manages complications, and determines whether referral to a transplant center is appropriate.
Transplant surgeons become involved only when surgery is being seriously considered. This is the major leagues of liver care, not the standard opening act.
Endocrinologists and obesity medicine specialists
MASLD is closely tied to metabolic health. An endocrinologist may help manage Type 2 diabetes, insulin resistance, thyroid disease, or other hormonal conditions. An obesity medicine specialist can provide structured weight-management treatment, including behavioral support and prescription medication when appropriate.
These specialists do not replace a liver specialist when advanced fibrosis is suspected. Instead, they address the metabolic forces that may continue feeding the disease.
Registered dietitians
A registered dietitian can translate broad advice such as “eat healthier” into an actual plan that works at breakfast, in restaurants, during travel, and on stressful Tuesday evenings when cooking feels like an Olympic event.
A dietitian familiar with liver and metabolic disease may recommend a Mediterranean-style eating pattern, less added sugar, fewer refined carbohydrates, more fiber, appropriate portions, and sustainable calorie reduction when weight loss is advised.
Other professionals who may join the team
Depending on individual needs, fatty liver disease care may also involve a cardiologist, bariatric surgeon, diabetes educator, exercise specialist, addiction medicine physician, behavioral health professional, pharmacist, or sleep medicine specialist.
Children should generally be evaluated by a pediatrician and, when specialist care is needed, a pediatric gastroenterologist or pediatric hepatologist.
Research basis: Yale Medicine, Johns Hopkins Medicine, Mount Sinai and UCSF Health.
When Should You See a Fatty Liver Disease Specialist?
Not every ultrasound showing liver fat requires an immediate hepatology appointment. Specialist evaluation is more important when there are signs that liver injury may be progressing or when the diagnosis is uncertain.
Reasons to discuss a gastroenterology or hepatology referral include:
- Persistently elevated liver enzymes
- An elevated or indeterminate fibrosis risk score
- Abnormal liver stiffness on elastography
- Low platelet levels or other possible signs of advanced liver disease
- Imaging findings suggesting nodularity, an enlarged spleen, or cirrhosis
- Type 2 diabetes combined with multiple liver risk factors
- Unexplained liver abnormalities after initial testing
- Possible MASH with moderate or advanced fibrosis
- Symptoms suggesting liver complications
- A need to consider liver-directed prescription treatment
Urgent evaluation is appropriate for yellow skin or eyes, vomiting blood, black stools, severe abdominal swelling, new confusion, fainting, or rapidly worsening weakness. These symptoms are not typical of uncomplicated fatty liver and may signal advanced liver disease or another serious condition.
What Happens During a Specialist Appointment?
The first appointment is usually more detective work than drama. The specialist will review your medical history, previous laboratory results, imaging reports, medications, supplements, alcohol intake, weight history, and family history of liver disease.
Expect questions about diabetes, blood pressure, cholesterol, sleep apnea, physical activity, eating patterns, and changes in body weight. Be honest about alcohol and supplements. The liver does not care whether an herbal capsule came in an attractive bottle with a leaf on the label.
The physical examination may include checking for an enlarged liver or spleen, abdominal fluid, swelling in the legs, muscle loss, jaundice, or skin changes associated with chronic liver disease. Many people with MASLD have no noticeable physical signs, especially during earlier stages.
Tests a Fatty Liver Specialist May Order
Blood tests
Bloodwork may include ALT, AST, alkaline phosphatase, bilirubin, albumin, platelet count, glucose, hemoglobin A1C, cholesterol, and triglycerides. Additional tests may rule out hepatitis, autoimmune disorders, iron overload, and other causes of liver injury.
Normal ALT and AST results do not guarantee that the liver is free of fibrosis. Specialists consider the entire clinical picture rather than giving two enzyme numbers authority over the whole organ.
FIB-4 and other fibrosis scores
The fibrosis-4 index, commonly called FIB-4, uses age, AST, ALT, and platelet count to estimate the likelihood of advanced fibrosis. It is inexpensive and can be calculated from routine laboratory results.
A low score may support continued monitoring in primary care. An indeterminate or elevated score usually leads to a second assessment, such as elastography or a specialized blood test. Cutoff values and interpretation can vary with age and clinical circumstances, so the result should be reviewed by a qualified clinician.
Ultrasound and elastography
A standard abdominal ultrasound can detect liver fat but cannot reliably determine whether inflammation or important fibrosis is present. Elastography measures liver stiffness, which can help estimate scarring.
Transient elastography, sometimes known by a common brand name such as FibroScan, is quick and noninvasive. Magnetic resonance elastography may be used when more detailed assessment is required or when other tests provide unclear results.
Liver biopsy
A liver biopsy is no longer necessary for everyone with suspected fatty liver disease. Noninvasive tests can identify many low- and high-risk patients without placing a needle into the liver.
A specialist may still recommend biopsy when the diagnosis remains uncertain, test results conflict, another liver disease is possible, or precise staging would meaningfully affect treatment. Biopsy can show fat, inflammation, liver cell injury, and the amount of fibrosis.
Research basis: NIDDK, AASLD, American Gastroenterological Association, MedlinePlus and the Department of Veterans Affairs.
How Specialists Treat Fatty Liver Disease
Weight management and physical activity
For people who are overweight or have obesity, gradual weight loss remains a central treatment. Losing approximately 3% to 5% of starting body weight may reduce liver fat, while larger losses of roughly 7% to 10% may be needed to improve inflammation and fibrosis.
Exercise can benefit liver and metabolic health even when the bathroom scale behaves like a stubborn household appliance. A specialist may recommend aerobic activity, resistance training, or a combination based on physical ability and medical conditions.
Cardiometabolic risk reduction
Managing blood sugar, blood pressure, cholesterol, triglycerides, sleep apnea, and smoking risk is essential. For many people with MASLD, cardiovascular disease represents a greater near-term threat than liver failure.
Statins are commonly used when medically indicated to reduce cardiovascular risk. Patients should not stop cholesterol medication merely because a scan shows fatty liver unless their clinician identifies a specific safety concern.
Prescription medication for selected patients
Treatment options have expanded. Resmetirom, sold as Rezdiffra, received accelerated FDA approval in 2024 for adults with noncirrhotic MASH and moderate to advanced fibrosis. Semaglutide, sold as Wegovy, received an FDA indication in 2025 for adults with noncirrhotic MASH and moderate to advanced fibrosis.
These medications are not intended for every person with liver fat, and they are not recommended as treatment for MASH-related cirrhosis under their current indications. A liver specialist may confirm fibrosis stage, review possible interactions, monitor side effects, and determine whether the expected benefits outweigh the risks.
Other medications may be prescribed for obesity, diabetes, cholesterol, or related conditions. Patients should avoid starting vitamin megadoses, “detox” powders, or herbal liver cleanses without medical advice. Some supplements can cause liver injury, proving once again that the word “natural” is not a safety certificate.
Bariatric treatment
For qualifying patients with obesity, metabolic or bariatric surgery may produce substantial and sustained weight loss. It can also improve metabolic health and fatty liver disease. Evaluation normally involves a multidisciplinary team, and advanced cirrhosis changes the risk-benefit calculation considerably.
Research basis: FDA, Mayo Clinic, NIDDK, AGA and Johns Hopkins Medicine.
How to Choose a Fatty Liver Disease Specialist
Start by checking whether the physician is board-certified in gastroenterology, hepatology, or transplant hepatology. A doctor who regularly treats MASLD and MASH may be more familiar with current risk-stratification tools and liver-directed therapies.
For complicated disease, consider a center that offers elastography, specialized radiology, registered dietitians, endocrinology, obesity medicine, bariatric services, clinical trials, and transplant care. Having these services under one roof can reduce the medical version of being transferred through six customer-service departments.
Practical considerations matter too. Check insurance coverage, referral requirements, appointment availability, telehealth options, and whether test results can be shared electronically with your primary care physician.
Questions to ask at the appointment
- Do I have simple steatosis, MASH, fibrosis, or cirrhosis?
- What is my fibrosis risk, and how was it calculated?
- Do I need elastography, MRI, or a liver biopsy?
- How often should blood tests and fibrosis assessments be repeated?
- What amount of weight loss would be medically meaningful for me?
- Should I completely avoid alcohol?
- Are my prescriptions and supplements safe for my liver?
- Am I eligible for an FDA-approved MASH medication?
- Should I meet with a dietitian, endocrinologist, or obesity specialist?
- Which symptoms should prompt urgent medical attention?
A Realistic Patient Experience: From Surprise Finding to a Care Plan
Consider a composite example based on experiences commonly encountered in fatty liver clinics. Daniel, age 52, visits his primary care physician for an annual examination. He feels reasonably well, although he is tired after work and has gained about 25 pounds over several years. His laboratory results show mildly elevated ALT, high triglycerides, and an A1C in the Type 2 diabetes range.
An ultrasound reveals excess fat in the liver. Daniel searches online that evening and encounters everything from reassuring articles to advertisements claiming his liver can be “flushed clean” by Friday. By bedtime, he is simultaneously convinced that nothing is wrong and that he needs a transplant before breakfast.
His primary care physician brings the situation back to Earth. She explains that liver fat is common but that the amount of scarring matters more than the ultrasound wording alone. She reviews his medications, asks about alcohol, orders tests for other liver conditions, and calculates his FIB-4 score.
The result is not clearly low risk, so Daniel is referred to a hepatologist. At the specialist appointment, he expects a lecture about every pizza he has ever eaten. Instead, the hepatologist focuses on patterns rather than blame. She explains the relationship among insulin resistance, diabetes, triglycerides, body weight, and liver inflammation.
Transient elastography shows increased liver stiffness, but there is no evidence of cirrhosis. Daniel is relieved, although he learns that moderate fibrosis still deserves serious attention. The hepatologist explains that the goal is not merely to normalize ALT. The broader goal is to reduce his risk of progressive liver disease, heart attack, stroke, kidney disease, and diabetes complications.
Daniel then meets a registered dietitian. Rather than handing him a list titled “Foods You Love and Must Never See Again,” the dietitian reviews his usual routine. His breakfast is replaced with a higher-protein, higher-fiber option. Sugary beverages are reduced gradually. Restaurant portions are divided before he begins eating, and vegetables appear more often without requiring him to become emotionally attached to kale.
An endocrinologist adjusts his diabetes treatment and discusses a medication that may also support weight loss. Daniel begins walking after dinner and adds simple resistance exercises twice a week. Progress is uneven. He loses weight, regains a few pounds during the holidays, and briefly assumes the entire effort has failed. His care team reminds him that chronic disease management is measured over months and years, not one ambitious Monday.
At follow-up, his A1C and triglycerides have improved, his weight is lower, and his liver enzymes have declined. Repeat fibrosis assessment is planned rather than performed every few weeks. The specialist also reviews his medication eligibility, vaccination status, alcohol intake, and warning symptoms.
The most useful part of Daniel’s experience is not a miracle cure. It is the creation of a coordinated plan. His primary care physician handles routine health needs, the hepatologist monitors liver risk, the endocrinologist manages diabetes, and the dietitian helps make recommendations livable.
Another patient might have a very different path. Someone with a low FIB-4 score may remain in primary care. A patient with cirrhosis may require cancer surveillance, endoscopy, and transplant evaluation. A child may need pediatric specialists and family-centered nutrition support. A person whose liver injury is partly related to alcohol may benefit from addiction medicine and behavioral healthcare.
The common theme is that successful fatty liver disease care is rarely about finding one heroic doctor. It is about matching the intensity of care to the level of risk and treating the liver as part of the whole body.
Conclusion
The right fatty liver disease specialist depends on disease severity. A primary care physician can often manage low-risk MASLD, while a gastroenterologist or hepatologist is appropriate when fibrosis risk is unclear or elevated. Endocrinologists, obesity medicine physicians, dietitians, cardiologists, bariatric teams, and transplant specialists may contribute when additional expertise is needed.
The central question is not simply whether fat appears in the liver. It is whether inflammation or fibrosis is present, what is driving the condition, and what can be done to reduce future risk. Modern noninvasive testing and newer treatment options make specialist care more useful than ever, but sustainable improvements in metabolic health remain the foundation of management.
Note: This article provides general educational information and does not replace personalized medical advice. Anyone with abnormal liver tests, suspected fibrosis, or symptoms of advanced liver disease should consult a qualified healthcare professional.
